Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2008.366 | Open-Label Extension Study of 23 mg Donepezil SR in Patients with Moderate to Severe Alzheimer | Prof. Mok C.T. Vincent |
| 2017.257 | Open-label Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis (NASH) |
Prof. WONG Vincent Wai Sun 黃煒燊 |
| 2006.368 | Open-Label Study of Bevacizumab (Avastin_) Plus Taxane Monotherapy or in Combination for the First-Line Treatment of Patients with Locally Recurrent or Metastatic Breast Cancer ATHENA (Avastin THErapy for advaNced bresAst cancer) | Dr. Ho Wing Ming |
| 2016.597 | Open-Label, Randomized Trial of Nivolumab (BMS-936558) plus Pemetrexed/Platinum or Nivolumab plus Ipilimumab (BMS-734016) vs Pemetrexed plus Platinum in Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC) Subjects with Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor Therapy |
Prof. MOK Tony Shu Kam 莫樹錦教授 |
| 2016.688 | Open-Label, Single Arm, Phase 3b, Multi-Center Study Evaluating the Impact of Venetoclax on the Quality of Life of Relapsed/Refractory Subjects with Chronic Lymphocytic Leukemia (CLL) Including Those with the 17p Deletion or TP53 Mutation OR Those Who Have Received Prior Treatment with a B-Cell Receptor Inhibitor |
Dr. WONG Raymond Siu Ming 王紹明醫生 |
| 2015.087 | Open-label, uncontrolled Phase II trial of intravenous PI3K inhibitor BAY 80-6946 in patients with relapsed, indolent or aggressive Non-Hodgkin’s lymphomas (Part B) | Dr. WONG Raymond Siu Ming |
| 2004.314 | Open, Randomized, Controlled, Multicenter Phase III Study Comparing 5-FU/FA Plus Irinotecan Plus Cetuximab Versus 5-FU/FA Plus Irinotecan as First-Line Treatment for Epidermal Growth Factor Receptor | Prof. Chan Tak Cheung Anthony |
| 2021.135 | Operative Mortality After Triple Valve Surgery: Prognostic Value of Simplified MELD-Na | Dr. LIM Kevin |
| 2019.618 | Opioid analgesics during and following radiotherapy treatment of head and neck tumours | Dr. CHAN Jason Ying Kuen |
| 2025.741 | Opportunistic Screening of Pancreatic Tumors in Non-Contrast CT | Dr. WONG Matthew Lun |
| 2015.718 | Opt-out HIV testing in out-patient setting | Prof. TAM Greta Chun Huen |
| 2004.081 | Optical Brian Imaging of Incidental and Intentional Memory Retrieval | PENNEY Trevor |
| 2025.720 | Optical Coherence Angiography as a novel diagnostic tool for evaluating Cerebral Small Vessel Disease severity and progression: A prospective cohort study | Dr. Szeto Simon Ka Ho |
| 2021.505 | Optical coherence tomography (OCT) for lung imaging |
Dr. YUAN Wu 袁武 |
| 2021.273 | Optical Coherence Tomography and Optical Coherence Tomography Angiography features in Cytomegalovirus Retinitis | Dr. WONG Po Yin |
| 2017.358 | Optical Coherence Tomography evaluation of Bioabsorbable Vascular Scaffold Technique with Magmaris | Prof. YAN Bryan Ping Yen |
| 2015.297 | Optical Coherence Tomography evaluation of Very Early eNdothelialization after Dual Therapy Drug-eluting Stent with EPC CaptURE (OCT-VENTURE) |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2025.417 | Optimal acute adult psychiatric in-patient care in Hong Kong: a mixed-method study | Ms. CHUNG Sui Mei |
| 2015.291 | Optimal Bioabsorbable Vascular Scaffold Technique for Complex Bifurcation Lesions |
Dr. YAN Bryan Ping Yen 甄秉言 |
| 2025.277 | Optimal Cancer Screening Strategy for Nasopharyngeal Carcinoma (NPC) by combining Epstein-Barr Virus (EBV) Antibodies, DNA, and Nasal Endoscopy EB 病毒抗体,核酸及鼻内窥镜检查相结合的鼻咽癌最优早筛策略研究 | Dr. LAM Jacky Wai Kei |
| 2024.134 | Optimal Dosage of Atropine and Red Light Combination Therapy for Myopia Treatment (LAMP-4) Study | Prof. YAM Jason Cheuk Sing |
| 2019.245 | Optimal proximal interphalangeal joint position for treatment of mallet finger: a cadaveric biomechanical study |
Dr. MAK Suk Ying 麥淑楹 |
| 2020.224 | Optimal Strategy for the Monitoring of Dialysis Adequacy in Peritoneal Dialysis Patients |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2005.442 | Optimal Time of Laparoscopic Cholecystectomy After Endoscopic Clearance of Endoscopic Bile Duct Stone Removal in Acute Cholangitis | Prof. NG Kwok Wai |
| 2017.240 | Optimal timing of umbilical cord clamping for term babies with natural birth – a randomised open-labelled trial |
Prof. TAM Wing Hung 譚永雄 |
| 2004.302 | Optimal Ventricular Resynchronization and Nt-proBNP in Heart Failure Therapy | Prof. Yu Cheuk Man |
| 2025.682 | Optimisation and Outcome Evaluation of a Just-in-time Adaptive Intervention (JITAI) for Sleep and Circadian Problems: A Micro-randomised Trial and a Randomised Controlled Trial |
Dr. HO Fiona Yan Yee 何欣儀 |
| 2005.121 | Optimisation of Antihypertensive Therapies: Application of Pharmacogenomic and Biochemical Technologies ptimisation of Antihypertensive Therapies: Application of Pharmacogenomic and Biochemical Technologies | Prof. Brian Tomlinson |
| 2009.217 | Optimise CRT | Prof. Yu Cheuk Man |
| 2025.851 | Optimising antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation: target trial emulation using healthcare big data | Dr. SO Chak Yu |
| 2025.438 | Optimising Postnatal Outcomes: Implementing the NuViva Programme |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2018.132 | Optimization of antibiotics treatment duration in bloodstream infections with a serum procalcitonin-based algorithm |
Dr. LI Timothy Chun Man 李俊文 |
| 2014.270 | Optimization of culture method for human adipose derived-msenchymal stem cells with minimal amount of fetal bovine serum | Prof. POON Wai Sang |
| 2022.159 | Optimization of Peritoneal Dialysis Prescription by Early Determination of Peritoneal Transport Characteristics |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2020.601 | Optimization of Urine Processing for Biomarker Development of Kidney Diseases |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2025.424 | Optimizing Early Childhood Development of Chinese Children from Low-Resource Settings by Leveraging Technology and Biological Data | Prof. Wong Patrick Chun Man |
| 2025.843 | Optimizing Elderly Hearing Nurse Clinics: A Cost-Effectiveness and Satisfactory Analysis | Dr. YEUNG David Chun Man |
| 2021.238 | Optimizing Predictions of Dyslexia Cross-Culturally: Chinese and English Compared | Prof. MCBRIDE Catherine |
| 2025.911 | Optimizing Recovery: The Early Effects of Pre- and Post-operative Occupational Therapy Home Visits on Patients Receiving Total Knee Replacement within an Enhanced Recovery After Surgery Program. | Mr. CHONG Hiu Shing |
| 2017.001 | Optimizing varices screening in cirrhotic patients with well-controlled chronic viral hepatitis: A prospective cohort study with transient elastography and multiparametric magnetic resonance imaging |
Dr. WONG Vincent Wai Sun 黃煒燊 |
| 2014.053 | Oral 5-aminosalicyclic Acid Withdrawal in Long Standing Inactive Ulcerative Colitis: A Double-blind, Randomized, Placebo-controlled Trial | Prof. NG Siew Chien |
| 2013.482 | Oral Arsenic trioxide in Management of Newly Diagnosed and Relapsed or refractory Acute Promyelocytic Leukemia (PML/RARα) in Children | Dr. LI Chi Kong |
| 2026.191 | Oral bacterial immunotherapy (Uromune) in long-term indwelling Foley catheter patients: a self-controlled pilot study for prevention of catheter-associated urinary tract infection (CAUTI) with microbiome and immune correlates | Dr. LIU Alex Qinyang |
| 2010.368 | Oral feeding performance in infants | Ms NG Sze Ka |
| 2014.638 | Oral Health of patients with different dental checkup habit in private dental practice, Cross sectional study | Dr. TANG Hoi Yi |
| 2004.058 | Oral Health Survey in Psychiatric Patients in Hong Kong | UNGVARI Gabor S |
| 2025.404 | Oral microbiome as a non-invasive diagnostic for early detection of colorectal neoplasia | Prof. YU Jun |
| 2011.171 | Oral motor skills in children with speech sound disorders of unknwn origin: a comparison with children normal speech | Prof Lee Kathy |
| 2023.529 | Orbital RadiothErapy, Sirolimus and Intravenous steroid for Primary Diplopia in Thyroid Eye Disease (RESIDE): a multi-center, double-masked, sham- and placebo-controlled randomized trial | Dr. Lai Kenneth Ka Hei |
| 2010.548 | Orbitofrontal gray matter volume among adult female patients with major depressive disorder | Prof. Tang Wai Kwong |
Page 194 of 288.